ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Oncobiologics Series A Warrant Expiring 2/18/2019 (delisted)

Oncobiologics Series A Warrant Expiring 2/18/2019 (delisted) (ONSIW)

0,151
0,00
( 0,00% )
Mis à jour : 01:00:00

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
0,151
Prix Achat
0,14
Prix Vente
1,25
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Clôture Veille
0,151
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume moyen (3 m)
-
Volume financier
-
VWAP
-

ONSIW Dernières nouvelles

Oncobiologics Appoints Randy Thurman to Board of Directors

CRANBURY, N.J., April 17, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced the appointment of Randy Thurman to its board of directors, effective April 13, 2018. At...

Oncobiologics Appoints Dr. Joerg Windisch to Board of Directors

CRANBURY, N.J., March 27, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced the appointment of Joerg Windisch, Ph.D. to its board of directors, effective March 23...

Oncobiologics Reports First Quarter Fiscal Year 2018 Results

CRANBURY, N.J., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today reported financial results and business highlights for its first fiscal quarter ended December 31...

Oncobiologics Receives Positive Nasdaq Listing Determination

CRANBURY, N.J., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) (NASDAQ:ONSIW) (NASDAQ:ONSIZ) announced today that on February 13, 2018, the Company received formal notice...

Oncobiologics Announces Term Extension of Series A Warrants

CRANBURY, N.J., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) (NASDAQ:ONSIW) (NASDAQ:ONSIZ) announced today an extension to the term for exercise of its publicly traded...

Oncobiologics Announces Term Extension of Series A Warrants

CRANBURY, N.J., Feb. 06, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (Nasdaq:ONS) (Nasdaq:ONSIW), a clinical-stage biopharmaceutical company focused on identifying, developing, manufacturing...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
SPPLSIMPPLE Ltd
US$ 1,13
(253,13%)
374,15M
NUWENewellis Inc
US$ 2,73
(100,74%)
98,63M
STAFStaffing 360 Solutions Inc
US$ 3,04
(78,82%)
51,47M
ADNAdvent Technologies Holdings Inc
US$ 3,24
(70,53%)
65,19M
OMICSingular Genomics Systems Inc
US$ 21,91
(62,78%)
301,3k
TOIIWOncology Institute Inc
US$ 0,0101
(-47,67%)
58,22k
SSPEW Scripps Company
US$ 2,245
(-36,22%)
3,99M
GCTKGlucoTrack Inc
US$ 1,15
(-33,91%)
78,77k
ILLRTriller Group Inc
US$ 2,9001
(-32,24%)
2,17M
ELABElevai Labs Inc
US$ 0,019925
(-31,06%)
239,48M
SPPLSIMPPLE Ltd
US$ 1,12
(250,00%)
374,16M
ELABElevai Labs Inc
US$ 0,019925
(-31,06%)
239,48M
NVDANVIDIA Corporation
US$ 137,10
(1,26%)
152,66M
SQQQProShares UltraPro Short QQQ
US$ 7,51
(0,94%)
152,46M
DJTTrump Media and Technology Group Corporation
US$ 33,9899
(11,22%)
107,21M
Aucune Discussion Trouvée
Ajouter une Discussion